Numab Therapeutics AG Email Format

Biotechnology ResearchZurich, Switzerland51-200 Employees

Numab Therapeutics AG is a Switzerland-based biopharmaceutical company focused on discovering and developing therapies built from multispecific antibody constructs for inflammatory diseases and cancer. It operates a differentiated platform that integrates multiple binding formats with engineering approaches and immunogenicity-reduction strategies, supported by in-house engineering expertise. The firm pursues a diversified pipeline expected to yield first- or best-in-class therapies and has built a track record of strategic collaborations with major pharmaceutical companies.

Based in Horgen in the Zurich region, Numab functions as a mid-sized biotechnology firm. In recent years, it has advanced partnerships with large pharmaceutical companies, and in September 2025 announced a collaboration with Boehringer Ingelheim.

Sign up for free to view info

Company overview Employee directory